These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2953095)

  • 21. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.
    Gores PF; Sutherland DE; Platt JL; Bach FH
    J Immunol; 1986 Sep; 137(5):1482-5. PubMed ID: 3091683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple donor allotransplantation. A new approach to pancreatic islet transplantation.
    Gotoh M; Porter J; Kanai T; Monaco AP; Maki T
    Transplantation; 1988 Jun; 45(6):1008-12. PubMed ID: 3132760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of transplantation tolerance in guinea pigs by spleen allografts. II. Responses in the mixed leukocyte reaction correlate with the tolerant state.
    Shevach EM; Chan C; Bitter-Suermann H
    J Immunol; 1982 Aug; 129(2):710-5. PubMed ID: 6211492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
    Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
    Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T lymphocyte indifference to extrathymic islet allografts.
    Coulombe M; Gill RG
    J Immunol; 1996 Mar; 156(5):1998-2003. PubMed ID: 8596055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice.
    Rodríguez-Barbosa JI; Haller GW; Zhao G; Sachs DH; Sykes M
    Transpl Immunol; 2005 Oct; 15(1):25-33. PubMed ID: 16223670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of rat islet allografts with the use of ultraviolet irradiation, without immunosuppression.
    Hardy MA; Lau H; Reemtsma K
    Transplant Proc; 1984 Jun; 16(3):865-9. PubMed ID: 6233774
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of reduction of class II antigens on the survival of pancreatic allografts.
    Spillenaar-Bilgen EJ; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):515-6. PubMed ID: 2495619
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro suppression of cytotoxic T cell generation by lymphocytes from mice rendered neonatally tolerant of class II MHC alloantigens.
    Powell TJ; Streilein JW
    Transplantation; 1991 Aug; 52(2):383-6. PubMed ID: 1831305
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolonged survival of donor skin grafts on mice bearing established islet of Langerhans transplants.
    Faustman DL; Hauptfeld V; Davie JM; Lacy PE
    Transplantation; 1985 Aug; 40(2):216-8. PubMed ID: 3927534
    [No Abstract]   [Full Text] [Related]  

  • 36. Extended survival of pancreatic islet allografts in the testis of guinea-pigs.
    Ferguson J; Scothorne RJ
    J Anat; 1977 Sep; 124(Pt 1):1-8. PubMed ID: 410772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fate of skin grafts from different inbred strains on nude mice bearing allogeneic thymus grafts.
    Isaak DD
    J Reticuloendothel Soc; 1978 Mar; 23(3):231-3. PubMed ID: 349153
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of timing of bone marrow injection on the prolongation of skin grafts in ALS-treated mice.
    Hartner WC; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):242-3. PubMed ID: 2650110
    [No Abstract]   [Full Text] [Related]  

  • 39. Reassessment of the role of class II antigens in skin graft rejection.
    Sachs DH; Stone K; Arn JS
    Transplant Proc; 1989 Feb; 21(1 Pt 1):595-7. PubMed ID: 2565057
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of allograft rejection by immunization with donor blood depleted of Ia-bearing cells.
    Faustman D; Lacy P; Davie J; Hauptfeld V
    Science; 1982 Jul; 217(4555):157-8. PubMed ID: 6806903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.